[1]
|
Puculek, M., Machlowska, J., Wierzbicki, R., et al. (2018) Helicobacter pylori Associated Factors in the Development of Gastric Cancer with Special Reference to the Early-Onset Subtype. Oncotarget, 9, 31146-31162.
https://doi.org/10.18632/oncotarget.25757
|
[2]
|
Matsunaga, S., Nishiumi, S., Tagawa, R., et al. (2018) Alterations in Metabolic Pathways in Gastric Epithelial Cells infected with. Microbial Pathogenesis, 124, 122-129. https://doi.org/10.1016/j.micpath.2018.08.033
|
[3]
|
Warren, J.R. and Marshall, B. (1983) Unidentified Curved Bacilli on Gastric Epithelium in Active Cllromc Gastritis. Lancet, 1, 1273-1275.
|
[4]
|
International Agency for Research on Cancer (lARC) (1994) Monographs on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, Liver Flukes and Helicobacter pylori. lARC Press, Lyon, 177-240.
|
[5]
|
Correa, P. (1995) Helicobacter pylori and Gastric Carcinogenesis. American Journal of Surgical Pathology, 19, 37-43.
|
[6]
|
刘炯, 李兆申. 幽门螺杆菌感染与胃癌发生[J]. 中国实用内科杂志, 2014, 34(5): 538-544.
|
[7]
|
Mera, R.M., Bravo, L.E., Camargo, M.C., et al. (2018) Dy-namics of Helicobacter pylori Infection as a Determinant of Progression of Gastric Precancerous Lesions: 16-Year Follow-Up of an Eradication Trial. Gut, 67, 1239-1246.
https://doi.org/10.1136/gutjnl-2016-311685
|
[8]
|
梁华敏, 李春燕, 黄唯, 谭建敏. 幽门螺杆菌感染与胃癌前疾病的关系[J]. 岭南急诊医学杂志, 2012, 17(2): 107-108.
|
[9]
|
周丽雅, 林三仁, 丁士刚, 黄雪彪, 郭长吉, 张莉, 崔荣丽, 金珠, 孟灵梅, 张静. 根除幽门螺杆菌对胃癌患病率及胃黏膜组织学变化的八年随访研究[J]. 中华消化杂志, 2005, 25(6) :324-327.
|
[10]
|
汤金海, 陈易, 陆海林, 赵光明, 徐华, 苏荣华. 根除幽门螺杆菌对胃黏膜组织学变化及胃癌患病率的3年随访研究[J]. 现代消化及介入诊疗, 2010, 15(1): 47-49.
|
[11]
|
张煜敏, 靖大道, 仇玉兰. 根除幽门螺杆菌对胃黏膜癌前病变的影响的Meta分析[J]. 临床消化病杂志, 2009, 21(5): 268-272.
|
[12]
|
Wong, B.C., Lam, S.K., Wong, W.M., et al. (2004) Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China: A Randomized Controlled Trial. JAMA, 291, 187-194.
https://doi.org/10.1001/jama.291.2.187
|
[13]
|
Uemura, N., Okamoto, S., Yamamoto, S., et al. (2001) Helicobacter pylori Infection and the Development of Gastric Cancer. New England Journal of Medicine, 345, 784-789. https://doi.org/10.1056/NEJMoa001999
|
[14]
|
Shimoyama, T., Fukuda, S., Tanaka, M., et al. (2000) Evaluation of the Applicability of the Gastric Carcinoma Risk Index for Intestinal Type Cancer in Japanese Patients Infected with Helicobacter pylori. Virchows Archiv, 436, 585-587. https://doi.org/10.1007/s004289900179
|
[15]
|
Ford, A.C., et al. (2014) Helicobacter pylori Eradication Therapy to Prevent Gastric Thematic in Healthy Asymptomatic Infected In-dividuals: Systematic Review and Meta-Analysis of Randomised Controlled Trials. BMJ, 348, 3174.
https://doi.org/10.1136/bmj.g3174
|
[16]
|
You, W.C., Brown, L.M., Zhang, L., et al. (2006) Randomized Dou-ble-Blind Factorial Trial of Three Treatments to Reduce the Prevalence of Precancerous Gastriclesions. Journal of the National Cancer Institute, 98, 974-983.
https://doi.org/10.1093/jnci/djj264
|
[17]
|
Mera, R., Fontham, E.T., Bravo, L.E., et al. (2005) Long Term Follow-Up of Patients Treated for Helicobacter pylori Infection. Gut, 54, 1536-1540. https://doi.org/10.1136/gut.2005.072009
|
[18]
|
Leung, W.K., Lin, S.R., Ching, J.Y., et al. (2004) Factors Predicting Progression of Gastric Intestinal Metaplasia: Results of a Randomized Trial on Helicobacter pylori Eradication. Gut, 53, 1244-1249.
https://doi.org/10.1136/gut.2003.034629
|
[19]
|
Lu, B., Chen, M.T., Fan, Y.H., et al. (2005) Effects of Helicobacter pylori Eradication on Atrophic Gastritis and Intestinal Metaplasia: A 3-Year Follow-Up Study. World Journal of Gastroenterology, 11, 6518-6520.
https://doi.org/10.3748/wjg.v11.i41.6518
|
[20]
|
Rokkas, T., Pistiolas, D., Sechopoulos, P., et al. (2007) The Long-Term Impact of Helicobacter pylori Eradication on Gastric Histology: A Systematic Review and Meta-Analysis. Helicobacter, 12, 32-38.
https://doi.org/10.1111/j.1523-5378.2007.00563.x
|
[21]
|
Lee, Y.C., Chen, T.H., Chiu, H.M., et al. (2013) The Benefit of Mass Eradication of Helicobacter pylori Infection: A Community-Based Study of Gastric Cancer Prevention. Gut, 62, 676-682. https://doi.org/10.1136/gutjnl-2012-302240
|
[22]
|
Mansour-Ghanaei, F., Joukar, F., Mojtahedi, K., et al. (2015) Does Treatment of Helicobacter pylori Infection Reduce Gastric Precancerous Lesions? Asian Pacific Journal of Cancer Prevention, 16, 1571-1574.
|
[23]
|
Rokkas, T., Rokka, A. and Portincasa, P. (2017) A Systematic Re-view and Meta-Analysis of the Role of Helicobacter pylori Eradication in Preventing Gastric Cancer. Annals of Gas-troenterology, 30, 414-423.
https://doi.org/10.20524/aog.2017.0144
|
[24]
|
Dore, M.P., Cipolli, A., Ruggiu, M.W., et al. (2018) Helicobacter pylori Eradication May Influence Timing of Endoscopic Surveillance for Gastric Cancer in Patients with Gastric Pre-cancerous Lesions: A Retrospective Study. Medicine (Baltimore), 97, e9734. https://doi.org/10.1097/MD.0000000000009734
|
[25]
|
刘文忠. 重视根除幽门螺杆菌预防胃癌[J]. 胃肠病学, 2017, 22(12): 705-710.
|
[26]
|
张国新, 党旖旎, 严谨. 胃癌前病变的治疗[J]. 医学与哲学(B), 2015, 36(11): 19-21+87.
|
[27]
|
王萍, 唐旭东. 慢性胃炎背景下胃癌前病变的疗效评价问题[J]. 现代中医临床, 2017, 24(6): 1-3+14.
|
[28]
|
李映姗, 杨晓军, 张理选. 胃癌前病变的病理类型与中医证型的相关性初探[J]. 新中医, 2015, 47(6): 231-233.
|